SVASE Event: 'VC Breakfast: Technology Partners: Focus On Life Sciences, Therapeutic Products, And Clean Tech' August 31, 2006

Event: 'VC Breakfast: Technology Partners: Focus On Life Sciences, Therapeutic Products, And Clean Tech'

Date: Thursday, August 31, 2006 At 08:00
Duration: 1 Hour 30 Minutes
Contact Info:
VCBC Chair: Jai Kumar, contact no. - 408-406-4693 Email: [email protected]
URL:
The featured VC will be Jim Glasheen, General Parntner, Technology Partners. www.technologypartners.com/

EVENT LOCATION: Townsend and Townsend and Crew LLP, 390 Lytton Avenue, Palo Alto, CA, 94301-1431

This event is co-sponsored by Townsend and Townsend and Crew LLP www.townsend.com.

Technology Partners
Founded over 20 years ago as a private venture capital firm, Technology Partners manages a total of more than $400 million of investment capital. Investments are being made currently from Technology Partners VII, L.P., a $250 million fund.

Technology Partners teams with visionary entrepreneurs to build successful new companies. We serve principally as a lead investor and business advisor to both Life Science and Cleantech companies. Over time, we have cultivated distinct "centers of excellence" in which we have deep industry knowledge, domain, experience, and technical expertise. By concentrating our investments within these "centers of excellence," we are better able to select potential investments, as well as provide valuable advice to assist our portfolio companies. Our current areas of focus are: Life Sciences: Neuroscience, Therapeutic Products, Cleantech: Energy Technology, Water Technology, Materials Science. While we generally invest in earlier-stage ventures, we will consider later-stage rounds, if the opportunities are compelling and in areas of strategic interest. Our typical initial investment ranges from $1-8M and our total investment per company is up to $25M.

Jim Glasheen
Jim joined Technology Partners from CIT Venture Capital, where he served as Managing Director, leading the Group's efforts in Life Science investing.

Previously, Jim was a leader within McKinsey & Company's Pharmaceutical and Medical Products Practice. Over the course of several years, Jim worked extensively with a broad range Life Science Companies on M&A, business development and strategic issues.

Jim earned a B.S. from Duke University in Biology / Mechanical Engineering and a M.A. and a Ph.D. from Harvard University in Biology. He also was a Deutsche Akademische Austauschdienst (DAAD) fellow at Universitaet des Saarlandes, Germany and a post-doctoral fellow at University of California, Berkeley. Jim has published several papers and had his research highlighted in several major media outlets, including: Nature, The New York Times, Scientific American, CNN, Die Zeit, and Le Monde.

Jim is on the Advisory Council of the Entrepreneurial Center at the University of California, Berkeley Also, Jim serves as an advisor to the National Science Foundation’s (NSF) SBIR program in Washington D.C. This successful and innovative program provides federal grants to start-up companies to fund research programs in areas that will have a significant commercial impact.

COST: $25 SVASE Members; $39 Affiliates; $49 Non-members. This event is for ENTREPRENEURS ONLY, BY PREREGISTRATION ONLY.

This event is co-sponsored by Townsend and Townsend and Crew LLP www.townsend.com.

CONTACT: VCBC Chair: Jai Kumar, contact no. - 408-406-4693
LOCATION: Townsend and Townsend and Crew LLP, 390 Lytton Avenue, Palo Alto, CA, 94301-1431

Official Website: http://www.svase.org/index.php?option=com_extcalendar&Itemid=149&extmode=view&extid=503